Login to Your Account

Other News To Note

Friday, August 23, 2013
• Nuvo Research Inc., of Mississauga, Ontario, said U.S. licensee Mallinckrodt, of St. Louis, said the FDA accepted for filing a new drug application for Pennsaid (diclofenac sodium topical solution) 2 percent.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription